Cost-effectiveness of ceftolozane/tazobactam compared to meropenem in ventilator-associated pneumonia.

ABSTRACT:

SUBMITTER: Buendia JA 

PROVIDER: S-EPMC12535120 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature